ArticleFrontiers in bioengineering and biotechnology2025
A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thanks to the diverse advantages of electrospun nanofibers, multiple drugs have been loaded in these nanoplatforms to be delivered healthily and effectively. Doxorubicin is a drug used in chemotherapy, and its various delivery and efficacy parameters encounter challenges, leading to the seeking of novel delivery methods. Researchers have conducted numerous laboratory investigations on the encapsulation of doxorubicin within nanofiber materials. This method encompasses various parameters for the production of fibers and drug loading, categorized into device-related, material-related, and study design parameters. This study employed a supervised machine-learning analysis to extract the influencing parameters of the input from quantitative data for doxorubicin-loaded electrospun nanofibers. The study also determined the significance coefficient of each parameter that influences the output results and identified the optimum points and intervals for each parameter. Our Support Vector Machine (SVM) analysis findings showed that doxorubicin-loaded electrospun nanofibers could be optimized through employing a machine learning-based investigation on the polymer solution parameters (such as density, solvent, electrical conductivity, and concentration of polymer), electrospinning parameters (such as voltage, flow rate, and distance between the needle tip and collector), and our study parameters, i.e., drug release and anticancer activity, which affect the properties of the drug-loaded nanofibers, such as the average diameter of fiber, anticancer activity, drug release percentage, and encapsulation efficiency. Our findings indicated the importance of factors like distance, polymer density, and polymer concentration, respectively, in optimizing the fabrication of drug-loaded electrospun nanofibers. The smallest diameter, highest encapsulation efficiency, highest drug release percentage, and highest anticancer activity are obtained at a molecular weight between 80 and 474 kDa and a doxorubicin concentration of at least 3.182 wt% with the polymer density in the range of 1.2-1.52 g/cm
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.